Anti-angiopoietin therapy with trebananib for recurrent ovarian cancer (TRINOVA-1): a randomised, multicentre, double-blind, placebo-controlled phase 3 trial
Titel:
Anti-angiopoietin therapy with trebananib for recurrent ovarian cancer (TRINOVA-1): a randomised, multicentre, double-blind, placebo-controlled phase 3 trial
Auteur:
Monk, Bradley J Poveda, Andrés Vergote, Ignace Raspagliesi, Francesco Fujiwara, Keiichi Bae, Duk-Soo Oaknin, Ana Ray-Coquard, Isabelle Provencher, Diane M Karlan, Beth Y Lhommé, Catherine Richardson, Gary Rincón, Dolores Gallardo Coleman, Robert L Herzog, Thomas J Marth, Christian Brize, Arija Fabbro, Michel Redondo, Andrés Bamias, Aristotelis Tassoudji, Marjan Navale, Lynn Warner, Douglas J Oza, Amit M